Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

U.S. Senators Bill Cassidy (R-La.) and Thomas Carper (D-Del.) are calling on the Centers for Medicare & Medicaid Services to lift regulations that deny insurance coverage for obesity drugs and that limit coverage of Intensive Behavioral Therapy amid the COVID-19 pandemic.

10 Jul 2020

New research can help overcome challenges in diabetes research

Scientists focused on finding better treatments or cures for types 1 or 2 diabetes are painfully aware of current limitations, including having to use animal tissue in studies that often don't translate to human trials.

9 Jul 2020

Corn-based diet with flavonoids alleviates IBD-like symptoms in mice

Flavonoids from a specific line of corn act as anti-inflammatory agents in the guts of mice with an inflammatory-bowel-disease-like condition, according to a team of researchers who said flavonoid-rich corn should be studied to determine its potential to provide a protective effect on human health.

7 Jul 2020

7 in 10 U.S. adults worry poor health will limit their life experiences, survey finds

Seven in 10 U.S. adults worry poor health will prevent them from doing all the things they'd like to do in life, according to a new survey from the American Heart Association and American Diabetes Association.

7 Jul 2020

Study reveals a new way to determine the age of insulin-storage parcels

A study in the Journal of Biological Chemistry describes a new way to determine the age of insulin-storage parcels, known as granules, and sheds light on how their age affects their release into the bloodstream.

7 Jul 2020

Study shows how non-alcoholic fatty liver disease causes Alzheimer's-like neuroinflammation

Research from University of South Carolina associate professor Saurabh Chatterjee's laboratory in Environmental Health Sciences, Arnold School of Public Health, and led by Ayan Mondal, a postdoctoral researcher from the same lab, has revealed the cause behind the previously established link between non-alcoholic fatty liver disease (i.e., NAFLD, recently reclassified as metabolic associated fatty liver disease or MAFLD) and neurological problems.

6 Jul 2020

Arrhythmic gut bacteria signatures predict type 2 diabetes risk

The microbial composition of the intestines is complex and varies widely from one individual to another. Many factors such as environmental factors, lifestyle, genetics or illnesses affect the intestinal ecosystem of helpful gut bacteria.

6 Jul 2020

New guidelines on assessment and management of type 2 diabetes in children, adolescents

A team of paediatric specialists, including an expert from the University of Adelaide, has produced new guidelines regarding assessment and management of type 2 diabetes (T2D) in Australian and New Zealand children and adolescents.

6 Jul 2020

Study: Oats and rye brans reduce weight gain, hepatic inflammation

In a newly published experimental study, the consumption of dietary fibre from oat and rye brans supported the growth of beneficial gut microbiota, which in turn ameliorated cholesterol metabolism, enhanced gut barrier function and reduced hepatic inflammation.

2 Jul 2020

Extended culture of human pancreatic slices as a model to study regeneration of beta cells

Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have developed a method allowing for the long-term culture of "pancreatic slices" to study the regeneration of the human pancreas in real time.

1 Jul 2020

Alzheimer’s drug could be re-purposed to reverse blood vessel damage in diabetes

Drugs that were developed to treat Alzheimer’s Disease could be re-purposed to prevent - or even reverse - the damage done to the blood vessels in people who are obese or suffer from type 2 diabetes, according to new research.

1 Jul 2020

Menopause can increase risk of metabolic syndrome, shows study

Perimenopause is a time when women become more vulnerable to a number of health problems. A new study based on data from the Canadian Longitudinal Study on Aging identified menopause as a risk factor for the development of metabolic syndrome or some of its components, including hypertension, central obesity, and high blood sugar. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).

1 Jul 2020

BMI should be assessed in management of COVID-19 patients

A new study published on the preprint server medRxiv* in June 2020 reports that obesity is a risk factor of composite poor outcome of COVID-19 disease. On the other hand, COVID-19 patients with 'composite poor outcome' have higher BMI. Therefore, BMI should be assessed in the management of COVID-19 patients, and special attention should be given to patients with obesity.

1 Jul 2020

Study explores time trends in pregnancy-related outcomes among women with type 1 diabetes

Researchers from the Joslin Diabetes Center investigated time trends in pregnancy-related outcomes among women with type 1 diabetes between 2004 and 2017, and found that the percentage of mothers with excess weight gain during pregnancy as well as the use of insulin pumps and CGMs increased significantly, while the prevalence of nephropathy fell dramatically to zero.

30 Jun 2020

Study shows generic drug does not slow kidney disease

Historically, half or more of people with type 1 diabetes develop kidney disease, which frequently progresses to kidney failure, requiring dialysis treatment or kidney transplantation for survival, according to a study in Diabetes Care.

26 Jun 2020

Genes associated with SARS-CoV-2 human lung cell infection

Now, a new study published on the preprint server bioRxiv in June 2020 attempts to make sense of this data to identify viral genes that are explicitly expressed in the cells infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could help reveal new therapeutic targets.

26 Jun 2020

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Senators Cassidy and Carper urge CMS to update restrictive coverage policies on obesity drugs and IBT

New research can help overcome challenges in diabetes research

Corn-based diet with flavonoids alleviates IBD-like symptoms in mice

7 in 10 U.S. adults worry poor health will limit their life experiences, survey finds

Study reveals a new way to determine the age of insulin-storage parcels

Study shows how non-alcoholic fatty liver disease causes Alzheimer's-like neuroinflammation

Arrhythmic gut bacteria signatures predict type 2 diabetes risk

New guidelines on assessment and management of type 2 diabetes in children, adolescents

Study: Oats and rye brans reduce weight gain, hepatic inflammation

Extended culture of human pancreatic slices as a model to study regeneration of beta cells

Alzheimer’s drug could be re-purposed to reverse blood vessel damage in diabetes

Menopause can increase risk of metabolic syndrome, shows study

BMI should be assessed in management of COVID-19 patients

Study explores time trends in pregnancy-related outcomes among women with type 1 diabetes

Study shows generic drug does not slow kidney disease

Genes associated with SARS-CoV-2 human lung cell infection

Promising treatment does not guard against complication in type 1 diabetes

New study comprehensively profiles environmental factors linked to childhood obesity

Obesity and COVID-19: Cause or effect?

PCOS subtypes associated with distinct genetic variations, finds study

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in